Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...
Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...
A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...
Introduction Despite its serious impact, anorexia nervosa (AN) remains one of the least understood mental illnesses, with significant gaps in effective treatment options. No medications have been ...
April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and execution of clinical supply shipments of ...
Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast ...
Although GLP-1 analogs were associated with increased risks for cognitive impairment, they had a larger, protective effect ...
While the primary motor endpoint showed modest improvement, more notable effects were observed in non-motor domains.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, ...
The term “placebo” can be dated back to at least the 1770s, the earliest recorded instances having occurred in the published ...
Skin-picking and hair-pulling disorders are “underrecognized, understudied, and undertreated,” a dermatologist told ...
Omalizumab, alone or with allergen immunotherapy for house dust mites, may reduce daily use of inhaled corticosteroids in patients with house dust mite-sensitized mild-to-moderate allergic asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results